Recombinant EPHA3 (Ifabotuzumab Biosimilar) antibody

Catalog No. ABIN6964432

The Humanized Monoclonal anti-EPHA3 (Ifabotuzumab Biosimilar) antibody (ABIN6964432) specifically detects EPHA3 (Ifabotuzumab Biosimilar) in ELISA and FACS. The antibody is reactive with Human samples.

Quick Overview for Recombinant EPHA3 (Ifabotuzumab Biosimilar) antibody (ABIN6964432)

Target: EPHA3 (Ifabotuzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This EPHA3 (Ifabotuzumab Biosimilar) antibody is un-conjugated

Application: ELISA, Flow Cytometry (FACS)

Grade: Research Grade

Product Details anti-EPHA3 (Ifabotuzumab Biosimilar) Antibody

Purpose: Anti-EPHA3 (ifabotuzumab biosimilar) mAb

Characteristics: KB-004, KB004

Purification: Purified from cell culture supernatant by affinity chromatography

Isotype: IgG1

Application Details

Application Notes: ELISA 1:5000-10000, Flow Cyt 1:100

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Reconstitute with deionized water

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Expiry Date: 12 months

Target Details for EPHA3 (Ifabotuzumab Biosimilar)

Target: EPHA3 (Ifabotuzumab Biosimilar)

Target Type: Biosimilar

Background: Synonyms: TYRO4, HEK4, ETK1, ETK, EK4, HEK

UniProt: P29320